Pharmadox Healthcare Ltd., S.C. Zentiva S.A.
PolandAll drugs from this manufacturer
-
The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage rivaroxaban 10 mg ATC: B01AF01
-
In adults, it is used to prevent strokes and other blood clots (in atrial fibrillation) and to treat and prevent blood clots in the veins of the legs and lungs. In children and adolescents (over 30 kg), it is used to treat blood clots after initial injectable treatment.
Dosage form: capsules, hard
Active substance Dosage rivaroxaban 15 mg ATC: B01AF01
-
In adults, the medicine is used to prevent strokes and other blood clots (in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (over 30 kg), it is used to treat clots after initial injectable treatment.
Dosage form: capsules, hard
Active substance Dosage rivaroxaban 20 mg ATC: B01AF01
-
The medicine is used in adults to reduce the risk of another heart attack or to reduce the risk of death from cardiovascular disease (e.g., after acute coronary syndrome). It is also used to reduce the risk of blood clots in people at high risk due to coronary artery disease or peripheral artery disease.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 2.5 mg ATC: B01AF01
-
Xanirva is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg ATC: B01AF01
-
Xanirva is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent the recurrence of blood clots in the veins of the legs or lungs. In children and adolescents (over 30 kg), it is also used to treat blood clots after initial injectable treatment.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg ATC: B01AF01
-
Xanirva is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and lungs. In children and adolescents (weighing over 30 kg), it is also used to treat clots following initial injectable treatment.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg ATC: B01AF01